IBS and IBD are not different severities of the same condition. They are fundamentally different diseases that happen to share overlapping symptoms. IBS (irritable bowel syndrome) is a functional disorder, meaning it changes how the gut behaves without causing visible damage. IBD (inflammatory bowel disease, including Crohn's disease and ulcerative colitis) is an immune-mediated condition that causes chronic inflammation, tissue destruction, and structural complications. Getting the distinction right matters because the treatments, monitoring, and long-term risks are completely different.
What Makes IBS Functional and IBD Inflammatory?
IBS is diagnosed using the Rome IV criteria: recurrent abdominal pain at least one day per week for three months, associated with changes in stool frequency or form. There is no blood test, imaging finding, or biopsy result that confirms IBS. It is a diagnosis of exclusion, meaning doctors arrive at it after ruling out other conditions. In IBS, the gut looks structurally normal on endoscopy, imaging, and biopsy. The problem is in how the gut functions, involving visceral hypersensitivity (increased pain signaling from the gut), altered motility, and disrupted communication between the brain and the digestive system.
IBD is different in a measurable, objective way. In Crohn's disease, inflammation can occur anywhere from the mouth to the anus, often in patches, and it extends through the full thickness of the bowel wall (transmural inflammation). In ulcerative colitis, inflammation is continuous and confined to the colon and rectum, affecting only the inner lining (mucosa). Both conditions produce visible damage on endoscopy: ulcers, cobblestoning, erythema, friability. Biopsies show characteristic patterns including crypt distortion, granulomas (Crohn's), and crypt abscesses (UC). Blood and stool markers of inflammation are typically elevated.
Why Does the Confusion Happen?
The overlap exists because both conditions produce bloating, abdominal pain, diarrhea, constipation, urgency, and fatigue. In the early stages of IBD, especially mild Crohn's disease, there may be no dramatic symptoms like bleeding or weight loss. The patient presents with what looks like textbook IBS, and without objective testing, the diagnosis sticks. A 2014 study by Bercik and colleagues found that IBD patients were approximately 3 times more likely to have been previously diagnosed with IBS compared to matched controls. This is not a rare event. It is a systemic pattern in how IBS diagnoses are made.
What Are the Red Flag Symptoms That Point to IBD?
Certain symptoms should always prompt further investigation for IBD, regardless of whether someone already carries an IBS diagnosis. These red flags are not definitive proof of IBD on their own, but they are uncommon in true IBS and demand explanation.
- Rectal bleeding or blood in stool: This is the single most important red flag. IBS does not cause bleeding. Any rectal bleeding should be evaluated with endoscopy.
- Unintentional weight loss: Losing weight without trying, especially more than 5% of body weight over 6 to 12 months, suggests malabsorption, inflammation, or both.
- Fevers: Low-grade fevers alongside GI symptoms suggest an inflammatory or infectious process, not a functional one.
- Nocturnal symptoms: Being woken from sleep by diarrhea, pain, or urgency is atypical for IBS. Functional symptoms generally do not disrupt sleep.
- Iron deficiency anemia: Unexplained anemia, especially iron deficiency, can indicate chronic blood loss from intestinal inflammation.
- Family history of IBD: First-degree relatives of IBD patients have a significantly higher risk, and IBS-like symptoms in this group should be investigated more aggressively.
- Perianal disease: Fistulas, abscesses, or fissures around the anus are hallmarks of Crohn's disease and are not caused by IBS.
â ī¸If you have been diagnosed with IBS and you are experiencing any of the symptoms listed above, do not assume they are part of your IBS. Request specific testing to evaluate for IBD. These symptoms require investigation, not reassurance.
Which Tests Separate IBS from IBD?
Several objective tests can distinguish between IBS and IBD. The most useful non-invasive first step is fecal calprotectin.
- Fecal calprotectin: A stool test that measures a protein released by white blood cells in the intestinal lining. A level below 50 mcg/g makes active IBD very unlikely. A meta-analysis by van Rheenen et al. (2010) found that fecal calprotectin had 93% sensitivity and 96% specificity for distinguishing IBD from IBS in adults. This is a simple, inexpensive test that should be part of any IBS workup.
- CRP (C-reactive protein): A blood marker of systemic inflammation. Elevated CRP can indicate active IBD, though normal CRP does not fully rule it out, especially in mild or isolated ileal Crohn's disease.
- ESR (erythrocyte sedimentation rate): Another blood marker of inflammation. Less specific than CRP but adds value when interpreted alongside other results.
- Complete blood count (CBC): May show anemia (low hemoglobin), elevated white blood cells, or elevated platelets, all of which can indicate chronic inflammation.
- Colonoscopy with biopsies: The definitive test. Allows direct visualization of the colonic and terminal ileal mucosa, plus tissue sampling. Biopsies can identify microscopic inflammation even when the mucosa appears grossly normal.
How Reliable Is Fecal Calprotectin?
Fecal calprotectin is one of the most useful screening tools in gastroenterology. At a cutoff of 50 mcg/g, it has a negative predictive value exceeding 95% for ruling out IBD in patients with IBS-like symptoms. This means that a calprotectin below 50 makes active IBD very unlikely, though not impossible. The test is less accurate in distinguishing between different causes of intestinal inflammation (it cannot tell IBD apart from infections or NSAID-induced enteropathy, for example), but for the specific question of 'is this IBS or IBD,' it performs well. NICE guidelines recommend fecal calprotectin as a first-line test for adults presenting with lower GI symptoms when IBD is being considered but cancer is not suspected.
âšī¸Fecal calprotectin can be elevated by NSAIDs (ibuprofen, naproxen), proton pump inhibitors, and active infections. If your result is borderline (50 to 150 mcg/g), discuss these potential confounders with your doctor before repeating the test or proceeding to colonoscopy.
Can You Have Both IBS and IBD?
Yes. This is an underappreciated reality. Studies estimate that 30 to 40% of IBD patients in clinical remission (normal inflammatory markers, healed mucosa on endoscopy) still meet Rome criteria for IBS. This is sometimes called 'IBD-IBS overlap' or 'functional symptoms in IBD.' The inflammation is controlled, but the gut's pain signaling and motility remain disrupted. This means that not every symptom in an IBD patient is caused by active inflammation, and not every symptom improvement requires escalating immunosuppressive therapy. It also means that an IBS diagnosis does not preclude a future IBD diagnosis. The two conditions can coexist, and symptoms should be reassessed if they change character or stop responding to treatment.
What Should You Do if You Are Not Sure?
If you have an IBS diagnosis and have never had objective testing (blood work, fecal calprotectin, or endoscopy), it is reasonable to request it. At minimum, fecal calprotectin and basic blood work (CBC, CRP, iron studies) can provide significant reassurance or identify the need for further evaluation. This is especially important if your symptoms are worsening, changing pattern, or not responding to standard IBS treatments. A diagnosis of IBS should be a considered conclusion after appropriate exclusion, not a default label applied to anyone with chronic gut symptoms.
Can IBS turn into IBD over time?
IBS does not transform into IBD. They are separate conditions with different underlying mechanisms. However, what can happen is that early IBD was misidentified as IBS from the start. As the IBD progresses, symptoms worsen or red flags emerge, and the correct diagnosis is eventually made. This gives the appearance of IBS 'turning into' IBD, but in reality the IBD was present all along. If your IBS symptoms are changing significantly or new symptoms like bleeding or weight loss appear, request re-evaluation.
Is there a blood test that can diagnose IBD?
No single blood test diagnoses IBD definitively. CRP, ESR, and CBC can indicate inflammation, and serological markers like ASCA (associated with Crohn's) and pANCA (associated with UC) may support a diagnosis, but none are confirmatory on their own. IBD diagnosis requires endoscopy with biopsies. Blood tests are useful for screening, monitoring, and raising or lowering suspicion, but they cannot replace direct visualization and tissue sampling.
How long does it take to get an IBD diagnosis after symptoms start?
Diagnostic delays vary widely. A 2019 study in the Journal of Crohn's and Colitis reported a median diagnostic delay of 9 months for UC and 15 months for Crohn's disease in Europe, though delays of several years are common, particularly when patients are initially diagnosed with IBS. Crohn's disease tends to have longer delays than UC because it can present without visible rectal bleeding and may only affect the small bowel, which is harder to evaluate.
My calprotectin was normal but I still have symptoms. Should I push for a colonoscopy?
A normal fecal calprotectin (below 50 mcg/g) makes active IBD unlikely but does not rule it out entirely. If you have red flag symptoms (bleeding, weight loss, family history of IBD, anemia), a colonoscopy is still warranted regardless of calprotectin level. If your symptoms are classic for IBS without red flags and calprotectin is low, your doctor may reasonably defer endoscopy. The decision should be individualized based on your complete clinical picture.
Does stress cause IBD the way it can worsen IBS?
Stress does not cause IBD. IBD is an immune-mediated disease with genetic and environmental triggers. However, psychological stress can worsen IBD symptoms and may increase the risk of flares in people who already have the disease. The relationship is similar in IBS, where stress is a well-established symptom amplifier. The difference is that in IBD, stress-related symptom worsening can sometimes reflect actual inflammatory activity triggered by stress-immune pathways, not just altered pain perception.